J Gynecol Oncol.
2020 Mar;31(2):e43. 10.3802/jgo.2020.31.e43.
Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
- Affiliations
-
- 1Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng, China.
- 2Jilin Province People's Hospital, Changchun, China.
- 3Department of TCM, Jilin Cancer Hospital, Changchun, China. yangjili9791@163.com
- KMID: 2470874
- DOI: http://doi.org/10.3802/jgo.2020.31.e43
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
- Recent Concepts of Human Papillomavirus Vaccine
- DNA vaccines targeting human papillomavirus-associated diseases: progresses in animal and clinical studies
- Efficacy of human papillomavirus vaccines including cross protection : A review of recent evidence
- Update of human papillomavirus vaccination
